ANDA 061896

LILLY

FDA Drug Application

Application #061896

Application Sponsors

ANDA 061896

LILLY

Marketing Status

• Discontinued: 001

Application Products

001

TABLET;ORAL

EQ 500MG BASE

0

ILOSONE

ERYTHROMYCIN ESTOLATE

FDA Submissions

	ORIG	1	AP	1975-01-03
MANUF (CMC); Manufacturing (CMC)	SUPPL	6	AP	1990-04-10
MANUF (CMC); Manufacturing (CMC)	SUPPL	8	AP	1990-04-10
LABELING; Labeling	SUPPL	9	AP	1991-10-23
LABELING; Labeling	SUPPL	10	AP	1991-09-05
LABELING; Labeling	SUPPL	11	AP	1990-04-16
LABELING; Labeling	SUPPL	12	AP	1991-01-14
MANUF (CMC); Manufacturing (CMC)	SUPPL	13	AP	1992-01-27
LABELING; Labeling	SUPPL	19	AP	1997-07-22

Submissions Property Types

ORIG	1	Null	0
SUPPL	6	Null	0
SUPPL	8	Null	0
SUPPL	9	Null	0
SUPPL	10	Null	0
SUPPL	11	Null	0
SUPPL	12	Null	0
SUPPL	13	Null	0
SUPPL	19	Null	0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 61896
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)